Purifying Antibodies Raised against Xenopus Peptides

Abstract

Antibody production for work in Xenopus involves the immunization of a host with an antigen, usually a Xenopus protein or peptide alien to the host. The antibody-containing serum, normally returned to the investigator by the company/bioresource unit where it was raised, is comprised of all proteins not used in blood clotting (coagulation) and all the electrolytes, antibodies, antigens, hormones, and any exogenous substances, such as drugs and microorganisms, that were in the blood. It is often necessary to separate the target antibody from the rest of the serum components to minimize nonspecific protein–antibody interactions in downstream applications (e.g., when performing western blotting). Most antibody production companies provide a column containing the peptide coupled to glass beads. A purification procedure for using this type of column (i.e., one that is based on controlled-pore glass beads) is described here.

Mycoplasma glycine cleavage system key subunit GcvH is an apoptosis inhibitor targeting host endoplasmic reticulum

“…Anti- M . bovis GcvH antibodies were purified from the murine serum anti-GcvH as described previously [ 87 ]. Three milliliters of antiserum were mixed with 6 ml of 60 mM sodium acetate (pH 4.0), and 100% caprylic acid (for a final concentration of 2.5%) was added while the mixture was stirred.…”

Mycoplasma hyopneumoniae membrane protein Mhp271 interacts with host UPR protein GRP78 to facilitate infection

“…Anti‐ M. hyopneumoniae Mhp271 antibodies were purified from the murine serum anti‐Mhp271 as described previously (Piccinni & Guille, 2020). Three milliliters of antiserum were mixed with 6 ml of 60 mM sodium acetate (pH 4.0), and 100% caprylic acid (for a final concentration of 2.5%) was added while the mixture was stirred.…”